Molecular typing of breast cancer: transcriptomics and DNA microarrays

Archive ouverte

Bertucci, F | Houlgatte, R | Nguyen, C | Benziane, A | Nasser, V | Granjeaud, S | Tagett, B | Loriod, Béatrice, B. | Giaconia, A | Jacquemier, J | Viens, P | Birnbaum, D

Edité par CCSD ; Elsevier -

International audience. Breast cancer is the most frequent and deadly cancer of women. Its great heterogeneity makes prognosis and response to current treatments highly variable and difficult to predict. Mammary oncogenesis remains poorly understood. These issues should benefit from recent development of techniques capable of large-scale molecular analyses. The use of cDNA array techniques allows for the simultaneous analysis of the mRNA expression levels of thousands of genes in mammary tumor cell lines and breast tumors. Expression profiles will help classify tumors and provide new prognostic tools and potential therapeutic targets. They will also boost our knowledge of the molecular events responsible for the development and progression of this cancer.

Consulter en ligne

Suggestions

Du même auteur

Gene expression profiles of poor-prognosis primary breast cancer correlate with survival

Archive ouverte | Bertucci, F | CCSD

International audience. The extensive heterogeneity of breast cancer complicates the precise assessment of tumour aggressiveness, making therapeutic decisions difficult and treatments inappropriate in some cases. Co...

Gene expression profiling of primary breast carcinomas using arrays of candidate genes

Archive ouverte | Bertucci, F | CCSD

International audience. Breast cancer is characterized by an important histoclinical heterogeneity that currently hampers the selection of the most appropriate treatment for each case. This problem could be solved b...

Prognosis of breast cancer and gene expression profiling using DNA arrays

Archive ouverte | Bertucci, F | CCSD

International audience. Breast cancer is a complex genetic disease characterized by the accumulation of multiple molecular alterations. The resulting clinical heterogeneity makes current therapeutic strategies-based...

Chargement des enrichissements...